Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,450Revenue (TTM) $M2,028Net Margin (%)4.8Altman Z-Score3.9
Enterprise Value $M4,089EPS (TTM) $3.3Operating Margin %6.9Piotroski F-Score6
P/E(ttm)45.9Beneish M-Score-2.5Pre-tax Margin (%)6.2Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %5.3Quick Ratio3.1Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %-7.9Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow57.0y-y EBITDA Growth Rate %-4.0ROA % (ttm)2.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)3.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)5.0Gross Margin Increase y-yY

Gurus Latest Trades with BIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIONWQ Managers 2016-06-30 Add0.2%$135.03 - $149.99
($142.54)
$ 151.256%Add 19.15%503,466
BIOMariko Gordon 2016-06-30 Buy 0.19%$135.03 - $149.99
($142.54)
$ 151.256%New holding20,392
BIOJoel Greenblatt 2016-06-30 Sold Out -0.1%$135.03 - $149.99
($142.54)
$ 151.256%Sold Out0
BIOJohn Rogers 2016-06-30 Reduce-0.04%$135.03 - $149.99
($142.54)
$ 151.256%Reduce -2.35%980,851
BIOMario Gabelli 2016-06-30 Reduce$135.03 - $149.99
($142.54)
$ 151.256%Reduce -4.96%63,200
BIOKen Fisher 2016-06-30 Add$135.03 - $149.99
($142.54)
$ 151.256%Add 4.65%281,583
BIOPrivate Capital 2016-03-31 Sold Out -0.25%$123.93 - $138.97
($131.21)
$ 151.2515%Sold Out0
BIOJoel Greenblatt 2016-03-31 Reduce-0.04%$123.93 - $138.97
($131.21)
$ 151.2515%Reduce -25.83%67,705
BIONWQ Managers 2016-03-31 Reduce-0.01%$123.93 - $138.97
($131.21)
$ 151.2515%Reduce -0.78%422,546
BIOMario Gabelli 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 151.2515%Reduce -0.75%66,500
BIOJohn Rogers 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 151.2515%Reduce -0.14%1,004,492
BIOKen Fisher 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 151.2515%Reduce -2.02%269,075
BIONWQ Managers 2015-12-31 Reduce-0.04%$134.34 - $141.7
($138.69)
$ 151.259%Reduce -4.00%425,876
BIOJoel Greenblatt 2015-12-31 Reduce-0.03%$134.34 - $141.7
($138.69)
$ 151.259%Reduce -21.15%91,287
BIOGeorge Soros 2015-12-31 Sold Out -0.01%$134.34 - $141.7
($138.69)
$ 151.259%Sold Out0
BIOJohn Rogers 2015-12-31 Add0.01%$134.34 - $141.7
($138.69)
$ 151.259%Add 0.58%1,005,947
BIOKen Fisher 2015-12-31 Reduce$134.34 - $141.7
($138.66)
$ 151.259%Reduce -0.32%274,634
BIOMario Gabelli 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 151.259%Reduce -1.76%67,000
BIOPrivate Capital 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 151.259%Reduce -1.87%14,402
BIOJohn Rogers 2015-09-30 Reduce-0.21%$133.19 - $151.93
($144.02)
$ 151.255%Reduce -10.94%1,000,161
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3829.55view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12026.73view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3927.37view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8531.26view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4132.92view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6236.24view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9335.86view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2235.51view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.635.05view

Press Releases about BIO :

Quarterly/Annual Reports about BIO:

News about BIO:

Articles On GuruFocus.com
Mariko Gordon Invested in 5 Companies in 2nd Quarter Aug 21 2016 
Royce 100 Fund Shareholder Letter Sep 20 2015 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 

More From Other Websites
BIO RAD LABORATORIES INC Financials Aug 11 2016
Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell... Aug 10 2016
ETF’s with exposure to Bio-Rad Laboratories, Inc. : August 9, 2016 Aug 09 2016
Bio-Rad Laboratories, Inc. :BIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 Aug 08 2016
BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report Aug 05 2016
Edited Transcript of BIO earnings conference call or presentation 3-Aug-16 9:00pm GMT Aug 03 2016
Bio-Rad Reports Second-Quarter 2016 Financial Results Aug 03 2016
Bio-Rad posts 2Q profit Aug 03 2016
Bio-Rad posts 2Q profit Aug 03 2016
Bio-Rad posts 2Q profit Aug 03 2016
BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 03 2016
Bio-Rad Reports Second-Quarter 2016 Financial Results Aug 03 2016
Q2 2016 Bio Rad Laboratories Inc Earnings Release - After Market Close Aug 03 2016
Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More Aug 02 2016
Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : BIO-US : July... Jul 27 2016
Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : BIO-US : July... Jul 13 2016
Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016 Jul 11 2016
Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016 Jul 11 2016
ETF’s with exposure to Bio-Rad Laboratories, Inc. : June 20, 2016 Jun 20 2016
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for... Jun 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)